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Mechanism of concentrating defect in hypercalcemia. Role of polydip-
sia and prostaglandins. This study investigates the mechanism of the
renal concentrating defect in a model of chronic hypercalcemia in the
rat (serum calcium 12.4 0.2 mg %). Maximal urinary osmolality was
1669 76 mOsm/kg H20 in hypercalcemic rats as compared to 2609
61 mOsm/kg H20 in pair-fed controls, P < 0.05. The nephrogenic
nature of the renal concentrating defect was demonstrated by unrespon-
siveness to exogenous AVP and comparable arginine vasopressin
(AVP) levels by radioimmunoassay (12.65 2.58 pg/mI in hypercalce-
mic rats as compared to 8.12 0.83 in controls). Since hypercalcemic
rats had higher water intake from day 2, the contribution of polydipsia
to the renal concentrating defect was studied in hypercalcemic rats who
were pair-watered which resulted in significant reduction of the poiy-
uria; however, mild but significant polyuria persisted. Maximal urinary
osmolality was significantly improved in pair-watered hypercalcemic
rats, but it was still impaired when compared to controls. The inner
medullary tissue solute content was found to correlate significantly with
the maximal urinary osmolality in all the three groups of animals. The
hypercalcemic ad lib water intake rats had the lowest tissue solute. This
was associated with a decrement in GFR coupled with an increment in
inner medullary plasma flow. The pair-watered hypercalcemic rats had
an intermediary tissue solute content, associated with a further decre-
ment in GFR but a normal inner medullary plasma flow. The normocal-
cemic rats with normal GFR and inner medullary plasma flow had the
highest tissue solute content. Since urinary prostaglandin E2 excretion
was increased markedly in both ad lib water and pair-watered hypercal-
cemic rats as compared to controls, the role of prostaglandin E2 in the
renal concentrating defect was investigated by determining the maximal
urinary concentration following prostaglandin inhibition achieved by
administration of indomethacin. Prostaglandin inhibition failed to im-
prove the renal concentrating defect in hypercalcemic rats. Our study
therefore demonstrates that chronic hypercalcemia causes renal con-
centrating defect of nephrogenic origin that is partially dependent on the
associated polydipsia and polyuria. The polyuria-polydipsia indepen-
dent component of the defect is associated with decreased inner
medullary tissue solute content. Despite very high prostaglandin E2
excretion rates, the renal concentrating defect appears to be prostaglan-
din independent.
Mécanisme du défaut de concentration dans l'hypercalcémie. Role de Ia
polydipsie et des prostaglandines. Ce travail étudie le mécanisme du
défaut de concentration rénale dans un modéle d'hypercalcémie chro-
nique chez le rat (calcémies 12,4 0,2 mg %). L'osmolalité urinaire
maximale était de 1669 76 mOsm/kg H2O chez les rats hypercalce-
miques par rapport a 2609 61 mOsm/kg H20 chez des contrôles
nourris de facon appariée, P < 0,05. La nature néphrogene du défaut de
concentration rénale a été démontrée par l'absence de réponse a I'AVP
exogène et des niveaux comparables d'arginine vasopressine (AVP) par
dosage radioimmunologique (12,65 2,58 pg/mI chez les rats hypercal-
cémiques par rapport a 8,12 0,83chez les contrôles). Puisque les rats
hypercalcemiques avaient un apport hydrique plus élevé a partir dujour
2, la contribution de la polydipsie au défaut de concentration rénale a
été étudiée chez des rats hypercalcémiques qui recevaient de l'eau de
facon appariée. Cela a entrainé une reduction significative de la
polyurie; néanmoins une polyurie modérée mais significative a persisté.
L'osmolalité urinaire maximale était significativement améliorde chez
les rats hypercalcémiques recevant de l'eau de facon appariée, mais est
restée anormale par rapport aux contrôles. Le contenu en solutés du
tissu médullaire interne a été trouvé significativement corrélé avec
l'osmolalité urinaire maximale chez les trois groupes d'animaux. Les
rats hypercalcémiques dont l'apport hydrique était libre avaient les plus
faibles concentrations de solutés tissulaires. Cela était associé avec une
diminution de la GFR couple avec une augmentation du debit plasma-
tique médullaire interne. Les rats hypercalcémiques recevant de l'eau
de facon appariée avaient un contenu tissulaire en salutes intermé-
diaire, associé avec une diminution plus forte de GFR mais un debit
plasmatique médullaire interne normal. Les rats normocalcemiques
avec GFR et debit plasmatique médullaire interne normaux avaient Ia
plus forte teneur en solutés tissulaires. Puisque l'excrétion urinaire de
prostaglandines E2 était augmentee de facon marquee chez les rats
hypercalcemiques recevant de l'eau ad libitum ou de facon appariée par
rapport aux contrôles, le role de Ia prostaglandine E2 dans le défaut de
concentration rénale a été étudié en determinant Ia concentration
urinaire maximale après inhibition des prostaglandines par administra-
tion d'indométhacine. L'inhibition des prostaglandines na pas permis
d'améliorer le défaut de concentration rénale chez les rats hypercalce-
miques. Notre étude démontre donc que l'hypercalcemie chronique
entralne un défaut de concentration rénale d'origine nephrogene. Ce
défaut de concentration rénale est partiellement dépendant de Ia
polydipsie et de Ia polyurie associées. La composante indépendante de
la polyurie et de la polydipsie de ce défaut est associëe avec une
diminution du contenu en solutés tissulaires médullaires internes.
Malgré des debits d'excrétion de prostaglandines E2 trés élevés, le
défaut de concentration rénale semble être indépendant des
prostaglandines.
The association of hypercalcemia with polyuria and a renal
concentrating defect has been widely recognized in both hu-
mans [1, 2] and experimental animals [3, 4]. One of the potential
mechanisms that has been proposed on the basis of studies in
experimental animals is a derangement on the generation of
medullary hypertonicity [5, 6]. The mechanism responsible for
this decrease in medullary tonicity remains controversial, as
decreased delivery of solute to the medulla due to decrease in
GFR [7], impaired solute transport in the ioop of Henle [8, 9],
and medullary washout [10] have been proposed as causative
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mechanisms. A similar decrease in medullary tonicity has been
shown to occur with excessive water intake and resultant
polyuria [11—141. Accordingly, the polyuria and the renal con-
centrating defect of hypercalcemia could be a consequence of
increased thirst and water intake. In this regard it has been
proposed that hypercalcemia itself may stimulate water intake
[15]. The relationship between an increase in water intake and
the polyuria and concentrating defect in hypercalcemia have
not been defined fully.
Recent in vitro studies have shown that calcium stimulates
renal prostaglandin (PG) biosynthesis [16, 17]. Since PGE2 has
been shown to enhance medullary blood flow [18—201, inhibit
active chloride transport in the ioop of Henle [21], reduce urea
reabsorption from the collecting duct [22], and antagonize the
hydroosmotic effect of arginine vasopressin (AVP) on the
collecting duct and toad bladder [23, 241, several of the postulat-
ed effects of hypercalcemia on the concentrating mechanism
could be related to enhanced medullary PG biosynthesis. It is
possible therefore that PG production, if also increased in
chronic hypercalcemia, could be pathogenetically important in
the concentrating defect. The in vivo data on this question is
conflicting at this time. The response to exogenous vasopressin
is impaired in acutely hypercalcemic dogs receiving PG inhibi-
tors [251. On the other hand, a more recent report found that the
polyuria in chronically hypercalcemic rats is abolished by
indomethacin as the response to exogenous vasopressin is
restored [26]. Whether or not the defect in maximal urinary
concentration is affected was not examined in either study. The
present experiments therefore were performed to (1) assess the
role of polydipsia in the polyuria and concentrating defect of
hypercalcemia, (2) assess the contribution of high water turn-
over and inner medullary plasma flow to the decrease in tissue
tonicity, and (3) determine the effect of chronic hypercalcemia
on PG excretion and their role in the concentrating defect.
Methods
All studies were performed on Sprague-Dawley rats weighing
between 225 and 325 g. The animals were fed a commercially
obtained normal diet (ICN Nutritional Biochemicals, Cleve-
land, Ohio) or an identical diet to which dihydrotachysterol
(Philips Roxan, Columbus, Ohio), 4.25 mg/kg of diet was added.
Such supplementation with vitamin D increased serum calcium
promptly to a mean of 12.4 0.2 mg % by day 3. This level
remained stable for the ensuing days of the study. The following
studies were undertaken.
Comparison of water intake in hypercalcemic and
normocalcemic rats and its relationship to polyuria and
impaired urinary concentration
Rats were placed in metabolic balance cages that separate
urine and feces and quantify food and water intake. Animals
were housed in temperature and humidity controlled rooms
with 12-hr light ar1 12-hr dark cycles. Three groups of rats were
studied: group 1, rats on a normal diet (N =34); group 2, rats on
the vitamin D supplemented diet allowed free access to water
(N = 28); and group 3, rats on the vitamin D supplemented diet
whose water intake was not allowed to exceed that of matched
normocalcemic controls (N = 34). Furthermore, since food
intake of hypercalcemic rats of the vitamin D supplemented diet
was lower than that of normal rats, to ensure similar caloric,
protein, and mineral intake (variables which are known to affect
the renal concentrating ability) food intake of control rats was
matched to that of groups 2 and 3 rats, who had similar levels of
food intake. Daily water intake, urine output, urinary osmolali-
ty, and weights were monitored.
To establish a temporal relationship between the onset of the
polydipsia-polyuria and the renal concentration, a 30-hr dehy-
dration test was performed on day 3, a time at which vitamin D
supplemented rats had an intake of water clearly higher than
controls (see below) (group I, normal diet, N = 6; group 2,
vitamin D supplemented diet, N = 8). The contribution of
polyuria and polydipsia to the concentrating defect of hypercal-
cemia was studied on day 7 by determining the maximal urinary
concentrating ability following a 30-hr dehydration in the three
groups of rats. To ensure maximal levels of circulating vaso-
pressin during the concentration test, six rats in each group
were also given an intramuscular injection of 500 mU of
vasopressin in oil (Parke Davis, Morris Plains, New Jersey) on
the day of dehydration, and the injection was repeated the next
morning when the final urine was being obtained. At the end of
the dehydration period, an unselected subgroup of rats from
each group (group 1, N 12; group 2, N = 13; group 3, N = 10)
were sacrificed for serum sodium and potassium (Flame Pho-
tometer) determinations. Another group of rats, which did not
receive exogenous AVP (group 1, N = 10; group 2, N = 10)
were guillotined, and free-flowing trunk blood was collected
into prechilled EDTA tubes (vacutainer tubes, Becton Dickin-
son and Co., Rutherford, New Jersey) for analysis of plasma
AVP levels by radioimmunoassay as previously described [271.
Role of polyuria and polydipsia on the content of tissue
solutes and its determinants in hypercalcemia
In these studies the inner medullary solutes of normocalce-
mic controls (group 1, N = 18), hypercalcemic on ad libitum
water (group 2, N = 13) and hypercalcemic pair-watered (group
3, N = 18) rats were determined following a 30-hr dehydration
period using a modification of the method of Appeibloom et al
[28]. Animals were anesthetized with pentobarbital (6 mg/100 g
body weight); the abdomen was opened and both kidneys were
removed rapidly and placed in an ice bath. We cut the kidneys
along their longitudinal axis, using a razor blade and scalpel; the
inner medulla was dissected free, freezed in liquid nitrogen, and
weighed immediately. One inner medulla was then homoge-
nized for the determination of sodium, potassium, and urea
nitrogen content, while the other was dried to constant weight
(72 hr) for determination of tissue water content. Sodium and
potassium concentrations were determined by atomic absorp-
tion spectrophotometer (Perkins Elmer, Norwalk, Connecticut)
while urea nitrogen was measured by an autoanalyzer (Techni-
con Instruments Corporation, Tarrytown, New York). The
inner medullary tissue osmolality was finally calculated from
the sodium, potassium, and urea contents.
Glomerular filtration rate studies. To determine whether or
not the decrease in inner medullary tissue solute content in
hypercalcemia (see below) is due to altered delivery of solute
and fluid to the medulla, clearance of inulin was carried out on
day 8 in the three groups of rats (group 1, N = 10; group 2, N =
8; group 3, N = 12). In these studies, rats were anesthetized
with ether, polyethylene catheters (PE5O) were inserted into the
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jugular vein and femoral artery for infusion, and blood sam-
pling, respectively, and the bladder was catheterized (PE6O)
with care to eliminate dead space. Animals were then allowed
to recover fully from anesthesia, while they were placed in
individual restraining cages. Blood pressure was continuously
monitored (Electronics for Medicine, White Plains, New York)
and inulin in 0.45% saline was infused at a rate of 0.6 cc/lOO g
body weight/hr, which produced constant plasma inulin levels
of approximately 20 mg/dl. After a 60-mm equilibration period,
the animals' urine flow was stable and two 30-mm urine
collections were obtained. Blood samples (200 pi) were drawn
in the middle of each collection period, and the volume was
replaced with 0.9% saline. The blood and urine were analyzed
for inulin concentration and inulin clearance was calculated in
the standard manner.
Inner medullary plasma flow studies. To determine whether
the decrease in inner medullary tissue content in hypercalcemic
rats (see below) is due to increased removal of solute from the
medulla because of enhanced inner medullary plasma flow,
inner medullary plasma flow was measured on day 8 of the
study in 12 rats in each of the three groups of animals using a
modification of the method of Lilienfield, Maganzini, and Bauer
[29], as described by Solez et al [301.
Animals were anesthetized by intraperitoneal injection of
ketamine hydrochloride 50 mg/kg (Parke Davis and Co., De-
troit, Michigan) and mactin 20 mg/kg (Guilden Konstanz, West
Germany, Distributors, Andrew Lockwood Assoc., Rochester,
Minnesota) and placed on a thermostatically controlled table
which maintained body temperature at 37°C. A tracheostomy
was performed. A PESO catheter for the infusion of 0.9% NaCl
containing 125j albumin (Mallinckrodt, St. Louis, Missouri)
colored with FD&C green dye number 3 (Keystone Aniline and
Chemical Co., Chicago, Illinois) was inserted into the jugular
vein. A suprapubic incision was made, the bladder was exter-
nalized, and a PE6O catheter with a flared end was inserted. The
left femoral artery was catheterized with PE5O tubing for blood
collection and continuous monitoring of blood pressure with an
electronic recorder (Electronics for Medicine, White Plains,
New York). Only animals with mean arterial blood pressure
greater than 100 mm Hg were utilized.
Animals were then prepared for the measurement of inner
medullary plasma flow. Following isolation of the kidney and
placement of the silk ligature (3-0), a microscope was positioned
over the kidney to assist in determining the time of arrival of
1251 albumin. The PESO catheter in the jugular vein was then
attached to a syringe on the infusion side of a reciprocal action
pump (Harvard Apparatus, Millis, Massachusetts) containing
1251 albumin colored with 25 mg/mI of FD&C green dye. The
femoral arterial catheter was attached to the withdrawal side of
the pump. The length of the two catheters was identical. After
the pump was started, timing of the perfusion began when the
dye reached the kidney. All perfusions were performed for 20
sec. Simultaneously, the pump was stopped and the renal
ligature pulled tight. Excess blood was expressed from the
kidney and, using a microscope, the entire inner medulla was
removed as one piece. The inner medulla was weighed and then
counted along with 25 j.d of arterial plasma collected during the
perfusion period in a biogamma II counter (Beckman, Irvine,
California). Inner medullary plasma flow was calculated using
the formula:
35
Day 1 2 3 4
Fig. 1. Daily water intake (m1124 hr) of pair-fed
(Group 1) and hypercalcemic rats (Group 2).
Inner medullary plasma flow (IMPF, ml/min/lOO g inner medul-
cpm/lO0 g inner medulla 60 sec/mm
lary weight) = x
cpm/ml plasma perfusion time (see)
Role of PG in the concentrating defect of hypercalcemia
Since recent in vitro studies have shown that calcium stimu-
lates renal PG biosynthesis which, by enhancing medullary
blood flow, inhibiting active chloride transport in the loop of
Henle, reducing urea reabsorption from the collecting duct, and
antagonizing the hydroosmotic effect of AVP on the collecting
duct, could contribute to the renal concentrating defect, studies
were performed to assess the role of PG in the renal concentrat-
ing effect of chronic hypercalcemia. In these studies, 24-hr
urinary samples were collected on day 7 of the study in 28
control, 28 hypercalcemic rats on ad lib water, and 18 water-
restricted hypercalcemic rats for determination of PGE2 by
radioimmunoassay using a urine modification of the procedure
of Dray, Charbonnel, and Matloux [311. Sodium azide was
added to the urinary samples to achieve a final concentration of
4 mg/cc. The role of PG in the renal concentrating defect was
further investigated by determining the maximal urinary con-
centration during PG inhibition. Animals were either given
indomethacin (5 mg/kg, i.p.) (Merck Sharp and Dohme, West
Point, Pennsylvania) or a carrier blank 6 hr prior to urine
collection during a 30-hr dehydration test (group 1, N = 8,
group 2, N = 11, group 3, N = 8). To ascertain the effects of this
dose of indomethacin on PG excretion and GFR, an additional
14 hypercalcemic rats were studied. After 24 hr of dehydration
seven animals received 5 mg/kg of indomethacin, and seven
animals received a carrier blank. Urine was collected in sodium
azide over the ensuing 6 hr for determination of PG excretion.
Immediately thereafter GFR was determined by inulin clear-
ance as described above.
Statistical analysis. A two-tailed unpaired Student's t test
was used to compare results in two different groups of animals
Group 2
o———o Hypercalcemic (N = 28)
—• Normocalcemic control
(N = 28)
65'
60
55
50
45
40
°P<0.05
I
////
Group 1
5 6 7
normocalcemic rats
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Table 1. Effect of 7 days of vitamin D-supplemented diet on serum calcium, serum sodium, serum potassium, solute excretion, and body
weight
Serum
calcium
mg/dl
Serum
sodium
mEqiliter
Serum
potassium
mEqiliter
Solute
excretion
mOsm/24 hr
Change in
weight
g17 days
Group 1
Normocalcemic
Control
10.0 145 4.2 28.8 10
2
Hypercalcemic
Adlibwater
12.4 141 4.1 28.3 —4
Group 3
Hypercalcemic
Pair-watered
12.4 144 4.2 26.6 —12
P value
Group I vs. Group 2
Group 2 vs. Group 3
Group 1 vs. Group 3
<0.05
NS
<0.05
<0.05
NS
NS
NS
NS
NS
NS
NS
<0.05
<0.05
<0.05
<0.05
and a one-way analysis of variance (with Student-Newman-
Keuls modification) [32j was used to compare multiple groups.
A P value less than 0.05 was considered significant. All data are
expressed as mean SEM.
Results
Water intake in hypercalcemic rats and its relation to polyuria
and impaired urinary concentration
The water intake of control rats (group 1) was essentially
unaltered in the 7 days of the study. However, the water intake
of rats on the vitamin D supplemented diet increased promptly
after institution of the diet. Water intake was significantly
higher than that of controls on day 2 and became increasingly so
in subsequent days (Fig. 1). Since the animals were pair-fed this
difference in water intake was not due to disparate food
consumption. In fact, solute excretion rates were similar (28.8
0.4 in controls and 28.3 0.6 mOsm/24 hr in experimental
rats) (Table 1).
To determine whether or not the increase in water consump-
tion in hypercalcemic rats precedes the development of a
concentrating defect, a 30-hr concentrating test was performed
on six controls and eight vitamin D supplemented rats on day 3
of the study. At this time, a concentrating defect was already
evident (2454 29 in controls and 1555 95 mOsm/kg H20 in
hypercalcemic rats, P < 0.05). In view of the very early onset of
this concentrating defect it could not be dissociated temporally
from the increase in water intake and a primary effect of
hypercalcemia to increase water intake independent of a defect
in urinary concentration cannot be demonstrated.
To determine whether polydipsia contributes to the polyuria
of hypercalcemia, daily urinary osmolalities and urine flows
were determined in 34 rats on the vitamin D supplemented diet
whose water intake was restricted to that consumed by control
rats (group 1). As is seen in Figure 2, the vitamin D supplement-
ed rats on ad lib water intake (group 2) had significant decreases
in urinary osmolality as of day 2 and increases in urine flow as
of day 3, in parallel with the above noted increase in water
intake. Water matching significantly reduced urine output in
group 3 rats when compared to rats on the same diet allowed ad
lib intake. This decrease in urine flow was not accompanied by
a parallel increase in urinary osmolality. Solute excretion was
only slightly lower (26.6 0.4) in these rats than in groups 1 and
2. However, it must be noted that these pair-watered hypercal-
cemic rats still had significantly higher urine flows and lower
urinary osmolalities than normocalcemic controls. This nega-
tive water balance was reflected in a somewhat greater loss in
body weight despite pair feeding (Table 1).
The contribution of the high water turnover on maximal
urinary concentration was determined in the three groups of
rats on day 8. Maximal urinary osmolality in rats on ad lib water
was 1669 76 mOsm/kg when compared to 2609 61 mOsm/kg
H20 in control rats (P < 0.05) (Fig. 3). This defect in maximal
urinary concentration was not corrected by exogenous vaso-
pressin. Furthermore, AVP levels obtained at the end of the
dehydration was slightly but not significantly higher in hyper-
calcemic rats (12.6 2.6 vs. 8.1 0.8 pg/ml in controls).
Hypercalcemic rats whose water turnover was decreased by
water restriction (group 3) had a significantly (P <0.05) higher
maximal urinary osmolality (2090 79 mOsmlkg H20) than
group 2 hypercalcemic rats, but they still had a significant
impairment when compared to controls. These results therefore
demonstrate that hypercalcemia causes a nephrogenic urinary
concentrating defect. Polydipsia contributes to both the poly-
uria and the defect in maximal urinary concentration, but there
is a remanent polydipsia independent component to the defect.
Effect of polyuria and polydipsia on tissue solutes and its
determinants in hypercalcemia
The water content of inner medullary tissue was similar in the
normocalcernic (82.9 0.9%) and hypercalcemic rats (group 2,
83.9 0.6%; group 3, 83.1 0.6%). Inner medullary tissue
tonicity was decreased markedly in hypercalcemic rats (851
79 mOsmlkg H20) when compared to normocalcemic controls
(1089 56 mOsm/kg H20, P < 0.05) (Fig. 4). Since high water
turnover itself can cause a washout of inner medullary solutes
[11—14], it was not clear whether the observed defect was a
consequence of hypercalcemia per se or of the polyuria and
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Fig. 3. Maximal urinary osmolality (mOsmlkg H20) of hypercalcemic
rats on ad lib water (hatched bar), pair-watered hypercalcemic rats
(cross-hatched bar), and pair-fed normocalcemic rats (open bar).
non-urea solutes was still significantly lower than that of control
rats (455 44 mOsm/kg H20 in ad lib water hypercalcemic rats;
460 20 mOsm/kg H20 in pair-watered hypercalcemic rats; 584
32 mOsm/kg H20 in control rats) (Fig. 4). Total osmolality of
the inner medulla was very significantly correlated (r = 0.99, P
<0.001) with the urinary osmolality. The mechanism responsi-
ble for the failure of hypercalcemic rats to generate normal
inner medullary tonicity was also investigated by assessing a
determinant of solute delivery (inulin clearance) and removal
(inner medullary plasma flow). As is shown in Figure 5, inulin
clearance was decreased in both groups of hypercalcemic rats
when compared to normocalcemic controls. On the other hand,
inner medullary plasma flow was increased significantly in
hypercalcemic rats on ad lib water but much of this increase
was not evident in equally hypercalcemic rats who were water-
matched.
Effect of chronic hypercalcemia on PG excretion and their
effect on urinary concentration
Urinary PGE2 excretion was increased markedly in hypercal-
cemic rats whether on ad lib (105 9 ng/24 hr) or water
restriction (146 17 ng/24 hr) when compared with normocal-
cemic controls (21 1 ng/24 hr) (Fig. 6). To determine whether
the high rate of PG production was contributing to or responsi-
ble for the defect in maximal urinary concentration was deter-
mined following the administration of the PG inhibitor indo-
methacin (5 mg/kg). This dose of indomethacin very significant-
ly decreased PG excretion in these hypercalcemic rats over the
last 6 hr of dehydration. Specifically, while PGE2 excretion was
20.2 2.0 ng/6 hr in the hypercalcemic rats receiving a blank, it
was only 4.3 0.9 ng/6 hr in indomethacin-treated rats (P <
0.001). In fact, this rate of PGE2 excretion is not significantly
different from that of normocalcemic indomethacin-treated rats
(2.5 1.0 ng/6 hr). Likewise this dose of indomethacin did not
affect GFR over this short period of administration, as inulin
clearance was 0.61 0.06 ml/min/gkw in blank-treated hyper-
calcemic rats and 0.55 0.06 ml/min/gkw in indomethacin-
treated rats. As is depicted in Figure 7, inhibition of PG
—m Normocalcemic control (N = 34)
——-.o Hypercalcemic, ad lib water (N = 28) T
. Group2Hypercalcemic, pair-watered (N = 34) //
/
Group 1
Day 1 2 4 5 7
NS
NS
NS
45
40
35
30
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15
P values
Group 1 vs. 2 0.05
Group 2 vs. 3 0.05
Group 1 vs. 3 0.05
1600
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800
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P values
Group 1 vs. 2 NS 0.05 0.05 0.05 0.05 0.05
Group 2vs.3 NS NS NS NS NS NS
Group 1 vs. 3 NS 0.05 0.05 0.05 0.05 0.05
Fig. 2. Daily urine output (m1124 hr) (upper panel) and daily urinary
osmolality (mOsmlkg H20) (lower panel) of pair-fed normocalcemic
rats (Group 1), hypercalcemic rats on ad lib water (Group 2), and pair-
watered hypercalcemic rats (Group 3).
polydipsia that accompanies it. In hypercalcemic rats who were
not allowed to increase their water intake and had only minimal
polyuria, tissue solute increased (952 52 mOsm/kg H20)
when compared to equally hypercalcemic rats on ad lib water
intake (851 79 mOsm/kg H2O), although this increase did not
reach statistical significance. The increase was entirely ac-
counted for by an increment in tissue urea content (396 46
mOsm/kg H20 in ad lib water hypercalcemic rats; 482 41
mOsm/kg H20 in pair-watered hypercalcemic rats; 512 46
mOsm/kg H2O in control rats) (Fig. 4). However, the content of
600
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0
P<0.05 I
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P<O.05
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NS
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D
P < 0.05
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P <0.05
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Hypercalcemic Hypercalcemic Normocalcemic
ad lib water pair-watered control
(N= 13) )N= 18) (N= 18)
Fig. 4. Inner medullary solute content (mOsm/kg H20): urea content
(lower panel); non-urea content (upper panel) of hypercalcemic rats on
ad jib water (hatched bar), pair-watered hypercalcemic rats (cross-
hatched bar), and pair-fed normocalcemic rats (open bar).
synthesis in the absence of alterations in GFR failed to signifi-
cantly improve or correct the abnormal urinary concentration
of hypercalcemic rats. The administration of indomethacin did
not significantly alter urinary concentration in either of the
hypercalcernic rats (Fig. 7).
Discussion
It is well established that hypercalcemia is associated with
profound alterations in water homeostasis characterized by
polyuria, polydipsia, and impaired maximal urinary concentra-
tion [1—4]. While the precise pathogenesis of the disorder has
not been defined fully, a decrease in medullary tonicity has
been demonstrated repeatedly [5—6]. The possibility that the
primary derangement could be an effect of hypercalcemia on
thirst has been proposed [15] but never documented. Further-
more, the contribution of the high rate of water turnover per Se
to the decrement in medullary tonicity and maximal urinary
concentration in chronic hypercalcemia has not been studied
previously.
Our initial studies were directed at determining whether
hypercalcemia has an effect on thirst. Water consumption of
rats placed on vitamin D supplemented diet increased very
promptly and was significantly greater than that of controls by
day 2. Since maximal urinary concentration was already im-
paired in hypercalcemic rats tested on day 3, we could not,
Hypercalcemic Hypercalcem Ic Normocalcemic
ad lib water pair-watered control
(N=12) (N12) (N=12)
Fig. 5. Glomerular filtration rate (mllminlgkw) (upper panel) and inner
medullary plasma flow (ml/min/100 g inner medulla weight) (lower
panel) of hypercalcemic rats on ad lib water (hatched bar), pair-watered
hypercalcemic rats (cross-hatched bar), and pair-fed normocalcemic
rats (open bar).
unlike the case of hypokalemia [33], ascertain whether polyuria
and polydipsia precede the onset of defective urinary concen-
tration. A significant contribution of primary polydipsia to the
high water turnover of hypercalcemia appears therefore to be
unlikely.
Our subsequent studies were directed at determining the
effect of water restriction on the water metabolism of the
hypercalcemic rat. To this end the intake of water allowed rats
on the vitamin D-supplemented diet was that consumed by
normocalcemic control rats. As is depicted in Figure 2, this
water restriction markedly decreased the polyuria of these rats
when compared with that of hypercalcemic rats on ad lib water
intake. However, their urine flow was slightly but significantly
higher than that of their normocalcemic water-matched con-
trols, a fact that was reflected in a decrease in body weight, but
not in an increase in serum sodium concentration (Table 1).
These observations further support, therefore, the view that the
polyuria and polydipsia observed in hypercalcemia is not entire-
ly due to polydipsia but rather is a water losing consequence of
defective renal concentration. It must be noted, however, that
the hypercalcemic rats did display considerable water-conserv-
ing ability as their urine flow dropped markedly when water
intake was restricted. In the recent observation of Serros and
Kirschenbaum [26], the decrease in urine flow brought about by
water restriction was very modest as the daily urine volume of
these water-restricted rats was still much closer to that of
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Fig. 6. Urinaryprostaglandin E2 excretion rate (ng124 hr) of hypercalce-
mic rats on ad lib water (hatched bar), pair-watered hypercalcemic rats
(cross-hatched bar), and pair-fed nor,nocalcemic rats (open bar).
nonrestricted hypercalcemic rats than to normocalcemic
controls.
In addition to decreasing daily urine flow, it is of note that
water-matched rats had a significant improvement, although by
no means correction, of maximal urinary concentration (Fig. 3).
Such an observation therefore strongly suggests that the con-
centrating defect that ensues in chronic hypercalcemia is at
least in part a consequence of the polyuria of the disorder. Our
measurements of inner medullary solutes in the three groups of
animals suggest a trend that may be responsible for this
observation. Thus, while as has been previously reported,
hypercalcemic rats had a decrement in tissue solutes, hypercal-
cemic water-restricted rats had an intermediate level of solute
concentration. It is also of interest that while hypercalcemic
rats on ad lib water appeared to have a decrement in both non-
urea (sodium and potassium) and urea solutes, the increment
seen by water restriction and decrease in urine flow was
entirely in the urea component (Fig. 4).
To elucidate the possible mechanisms responsible for the
observed impairment in solute generation, we assessed two
additional factors involved in the process. We measured inulin
clearance, a determinant of solute delivery, and inner medullary
plasma flow, a determinant of solute removal. As has been
observed in all but one study [26], GFR is reduced in chronic
hypercalcertiia. Since fractional delivery of solutes to the early
distal tubule is normal in such animals [7], the absolute delivery
to the loop is probably decreased. It is therefore likely that this
accounts at least in part for the decreased tissue solutes
independent of whether an additional defect in the loop of
Henle is [8] oris not [7, 34] operant. Our measurements of inner
medullary plasma flow reveal that hypercalcemic rats on ad lib
intake have a marked increase in blood flow to this region of the
kidney. Thus a decrement in GFR coupled with the increment
in inner medullary plasma flow probably account for the
decrease in tissue solute observed in these hypercalcemic rats.
The increase in inner medullary plasma flow appears to be a
consequence of the high urine flow [35] rather than hypercalce-
mia per se [10] as it was not observed in equally hypercalcemic
water-matched nonpolyuric rats. In fact, as noted above, these
Hypercalcemic Hypercalcemic Norniocalcemic
ad lib water pair-watered control
(N = 16) (N = 11) (N = 24) (N = 8) (N = 24) (N=8)
Fig. 7. Maximal urinary osmolality (mOsmlkg 1120) following prosta-
glandin inhibition of hypercalcemic rats on ad lib water (hatched bar),
pair-watered hypercalcemic rats (cross-hatched bar), and pair-fed
normocalcemic rats (open bar).
rats had a somewhat higher content of tissue solutes despite a
further small decrease in GFR, presumably because the inner
medullary plasma flow was not increased. As may have been
predicted, normocalcemic rats with normal GFR and inner
medullary plasma flow had the highest inner medullary tissue
concentration. Since factors other than GFR and inner medul-
lary blood flow are probably also responsible for determining
solute accumulation in the inner medulla [36], we cannot
exclude the possibility that these are also operant in hypercalce-
mia. Taken together, we can conclude from this aspect of our
experiments that primary polydipsia was not demonstrable in
the chronically hypercalcemic rat. Nonetheless the high rate of
water turnover that ensues contributes to the severity of the
concentrating defect. This contribution is mediated by a greater
decrement in inner medullary solutes in association with an
increment in inner medullary flow. The polyuria-polydipsia
independent component of the defect is associated with residual
decrement in tissue solutes (primarily non-urea) as a conse-
quence of either decreased delivery to [7, 34] or decreased
uptake of solutes by the ascending limb [81.
In view of the compelling evidence that PG play an important
role in antagonizing the hydroosmotic action of vasopressin [23,
24] and since calcium appears to be an important stimulant of
renal synthesis of PG [16, 17], it seemed attractive to postulate
that an excess in PG could be important in the pathogenesis of
the abnormal concentrating defect in hypercalcemia. We also
found, using an immunoassay for PGE2 for the first time, that
chronically hypercalcemic rats had a higher rate of PG excre-
tion. This effect did not appear to be mediated by an increase in
urine flow rate [37, 38] as hypercalcemic rats who were water-
restricted and whose urine flow was lower had an even higher
rate of PGE2 excretion. Our data demonstrate that inhibition of
PG synthesis as was achieved in our rats during the last 6 hr of
dehydration does not improve the maximal urinary concentrat-
ing ability of hypercalcemic rats. Furthermore, this short-term
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inhibition of PG synthesis was not associated with the alter-
ations in GFR that are observed with longer periods (24 hr) of
indomethacin administration [391. These results, therefore,
suggest that the increased PG in hypercalcemia are not patho-
genetically important in the concentrating defect. It is of
interest to contrast our results with those of the recent study of
Serros and Kirschenbaum [261, who arrived at an opposite
conclusion, as these authors noted that indomethacin restored
responsiveness to vasopressin in hypercalcemic rats. Since
such a response requires an increase in urinary osmolality to
only 500 to 600 mOsm/kg H20, a urinary concentration that can
certainly be attained in hypercalcemia, it cannot be extrapolat-
ed to the impairment in maximal urinary concentration which
requires the generation of a much more concentrated intersti-
tium and urine. Our results in fact demonstrated that this defect
in hypercalcemia is not ameliorated by acutely inhibiting the
synthesis of an endoperoxide derivative. It must be noted that a
more chronic and not readily reversible consequence of excess
PG synthesis could be operant, and thus cannot be excluded by
our studies. Thus, for example, a PG-mediated effect on sodium
reabsorption in the thick ascending limb [211 leading to de-
creased interstitial tonicity may not be readily reversible. In
fact, contrary to the observation made in the normal Sprague-
Dawley rat given indomethacin [401, we have not found an
increase in inner medullary solute content in hypercalcemic PG
inhibited rats (unpublished data). On the other hand, if PG were
antagonizing vasopressin action by a direct cellular effect, an
improvement in urinary concentration should have been
observed.
In summary, the results of this study do not provide evidence
for a primary effect of hypercalcemia on water intake. Nonethe-
less the polyuria and polydipsia of the disorder significantly
contribute to the concentrating defect that ensues. The poly-
uria-polydipsia independent component of the defect is associ-
ated with a decrease in tissue tonicity accompanied by a
decrement in GFR but not an increase in inner medullary
plasma flow. A concomitant cellular defect may also be operant
in hypercalcemia, but this appears to be independent of PG
synthesis.
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